Sit-to-Stand Progression Using Movi Chair vs Traditional Practices
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Most activities of daily living require unassisted ability to stand from a sitting position. Therefore, physical therapy exercises aimed at improving this essential action are critically important for patients with impaired functional mobility. Although sit-to-stand tests are a well-known tool used to assess physical function, they have only recently has been proposed for systematic strength training.
Those patients who would most benefit from sit-to-stand training require moderate assist or greater. However, these patients have significant difficulty initiating sit-to-stand exercises from a horizontal chair surface and have been largely excluded from prior studies examining sit-to-stand for strength training. These patients have been excluded not only because they cannot safely stand on their own, but also because manually lifting these patients poses a significant lifting-injury risk to physical therapists.
Movi is a commercially available hybrid mechanical lift and chair who's key feature is a built in battery powered motor (rated for 600 lbs) that pivots on its axis to raise and lower a patient up to 20 degrees. We believe that this feature represents an opportunity for introducing sit-to-stand strength training to previously excluded moderate assist patients. Progressively lowering the chair's angle of inclination over consecutive physical therapy sessions will allow the patient to practice sit-to-stand at a reduced effort until the to horizontal angle is reached.
As sit-to-stand strength training is a concept only proposed in 2011, no previous studies exist concerning a sit-to-stand physical therapy protocol using a chair progressively lowering the seat's angle of inclination. Currently, therapists use their clinical judgment when approaching patients with difficulty standing by utilizing exercise, skill repetition, in addition to other strengthening strategies and equipment to reach goals. Timed sit-to-stand has already been used at UAB in order to test a patient's progress in physical therapy but not as a therapy protocol in itself, partly because equipment allowing progressive lowering of the seat's angle of inclination has not been available until now. This study was conceived due to the great variability of physical therapy in the Hospital setting and the critical need for standardization and evaluating a protocol that has potential to positively impact patient speed and ease of recovery to prior level of functioning.
The therapy protocol utilizing the Movi chair will include the following:
- Mobilize patient to Movi chair (via lift or manual transfer)
- Document lowest height in 5 degree increments (in degrees from inclinometer attached to Movi chair) where patient is able to complete a sit-to-stand transfer with minimal assistance (defined as requiring < 25% effort from the physical therapist) allowing patient to use his or her arms on thighs or armrests if needed.
- The patient will perform 5 sit-to-stand transfers from this level, rest until recovery, and do additional sets to increase muscle strength only if able.
- During subsequent visits, patient will begin at prior set level. If able to perform a sit-to-stand transfer with less than minimal assistance, the elevation of the chair will be lowered by 5 degree increments until able to complete a sit-to-stand transfer with minimal assistance or greater and the patient will perform sit-to-stand transfer repetitions from the new height.
- This protocol will continue until the patient is able to perform a sit-to-stand transfer from a standard height chair with supervision assistance or until the patient is discharged to the next level of care
i. Once able to complete a sit-to-stand transfer from a standard height, a five-time-sit-to-stand (FTSST) will be performed 3 times per week.
Treatment of the control group will utilize standard recliners and traditional therapy methods (transfer training, therapeutic exercise). Once an investigator consents the patient for the study, if the patient has been randomized to either control group or intervention group, a non-investigator physical therapist will perform his or her usual physical therapy exercises to minimize bias from study investigators completing therapy. Investigators will test FTSST time for patients in the control group 3 times per week. Only investigators will treat the intervention group using the above outlined protocol 3 times per week. Once intervention group patients are able to complete a sit-to-stand transfer from a standard height, a FTSST will be performed 3 times per week by a study investigator. Investigators will also record the Hierarchical Assessment of Balance and Mobility (HABAM) score for intervention group patients when they test FTSST time as an added measure of mobility. The HABAM is an interval level mobility instrument that is already in use as a valid and reliable mobility instrument in the older acute medical population. This score does not require any additional exercises with the patient beyond the FTSST. Investigators will ask the non-investigator physical therapists caring for the control group patients to estimate control group patients' HABAM, which can be easily estimated after working with the patient during routine standard of care therapy.
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
- University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients receiving physical therapy at UAB hospital that require moderate assistance or greater with sit-to-stand transfers during initial evaluation
- Patients with baseline function of supervision as obtained in the initial physical therapy (PT) evaluation
- Patients who have an inpatient hospital stay of at least 4 days
Exclusion Criteria:
- Patients with diagnoses that are progressive in nature
- Patients in intensive care units due to critical medical condition and confounding factors
- Patients with cognitive impairment as noted in the medical record
- Patients with weight bearing precautions other than free weight bearing (FWB) or weight bearing as tolerated (WBAT)
- Children (under the age of 18), prisoners and pregnant women
- Patients who are not able to speak English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention Group
Patients to receive standard-of-care physical therapy + sit-to-stand therapy using the Movi chair 3x/wk.
|
Standard-of-care physical therapy 3x/wk for approximately 30 minutes each time + sit-to-stand training using the Movi chair 3x/wk for approximately 10 minutes each time.
|
|
ACTIVE_COMPARATOR: Control Group
Patients to receive standard-of-care physical therapy 3x/wk.
|
Standard-of-care physical therapy 3x/wk for approximately 30 minutes each time.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of progression from moderate to minimal assist
Time Frame: Through study completion, an average of 2 weeks
|
Patient rate of progression from moderate (<50% assistance from physical therapist) to minimal (<25% assistance from physical therapist) assist during hospital admission
|
Through study completion, an average of 2 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hierarchical Assessment of Balance and Mobility Score
Time Frame: Through study completion, an average of 2 weeks
|
Score grading the patient on balance, mobility, and transfers on a 0-28 scale
|
Through study completion, an average of 2 weeks
|
|
Five-time sit-to-stand time
Time Frame: Through study completion, an average of 2 weeks
|
Time for patient to complete sit-to-stand 5x from standard chair
|
Through study completion, an average of 2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Lavon Beard, DPT, MBA, Manager Physical Therapy, Doctor of Physical Therapy
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- X161207007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
NCT06623604CompletedPhysical Activity | Physical Activity Behavior | Physical Activity Levels
-
NCT05397561CompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity Facilitators
-
NCT07498608Enrolling by invitationPhysical Activity | Running | Running Performance | Running Endurance | Physical Activity in Adults | Physical Activity Intensity
-
NCT04299061WithdrawnPhysical Activity Level | Physical Activity Awareness
-
NCT06509061CompletedPhysical Activity | Physical Activity Self-Definition
-
NCT07543614RecruitingQuality of Life | Physical Activity | Physical Disability | Physical Function | Participation
-
NCT07158866Active, not recruitingPhysical Activity | Physical Fitness | Well Being
-
NCT07112469CompletedModerate Physical Activity (MPA) | Vigorous Physical Activity (VPA) | Moderate to Vigorous Physical Activity (MVPA) | Total of Sleep Time (TST)
-
NCT06854289Not yet recruitingUniversity Students | Physical Activity Level | Postural Awareness | Physical Activity Attitude
-
NCT03493633TerminatedPhysical Activity | Physical Disability
Clinical Trials on Standard-of-Care Therapy + Sit-to-Stand Therapy
-
NCT06544876RecruitingHealthy Aging | Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy Type 2 | Diabetic Peripheral Neuropathy Type 2 - Uncontrolled
-
NCT05056454CompletedDepression | Anxiety | Pregnancy Related | Perinatal Depression
-
NCT05840315CompletedSarcopenia | Hip Fractures | Fall Injury
-
NCT04174664UnknownExercise Capacity | Cystic Fibrosis in Children
-
NCT03888508Completed
-
NCT04045470RecruitingCutaneous T Cell Lymphoma | Peripheral T Cell Lymphoma
-
NCT06328699Active, not recruiting
-
NCT02527356CompletedChildren With Mobility Disabilities
-
NCT04778475CompletedStroke, Acute | Physical Disability | Mobility Limitation